Head-to-head · computed 2026-08-11
Hims & Hers vs LifeMD
Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping. LifeMD: LifeMD attaches a $149/month program fee to medication pricing; its compounded tirzepatide all-in figure ($597) is the highest in our index, though its insurance-navigation pathway for brand products is a genuine strength.
Tirzepatide
| Hims & Hers | LifeMD | |
|---|---|---|
| All-in maintenance | $548/mo | $597/mo |
| Best plan rate | $548/mo | $597/mo |
| 12-month total | $6,576 | $7,164 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Hims & Hers's $548 a month undercuts LifeMD's $597 by $49 a month at the 10 mg/wk maintenance basis — $588 across a year. Hims & Hers's figure is reported (captured 2026-08-11) and LifeMD's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's tirzepatide ladder runs $548 a month billed monthly. LifeMD's runs $597 a month billed monthly. On the twelve-month basis Hims & Hers's $6,576 beats LifeMD's $7,164 by $588 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Hims & Hers | LifeMD | |
|---|---|---|
| All-in maintenance | $453/mo | $348/mo |
| Best plan rate | $453/mo | $348/mo |
| 12-month total | $5,436 | $4,176 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, LifeMD's $348 a month undercuts Hims & Hers's $453 by $105 a month at the 2.4 mg/wk maintenance basis — $1,260 across a year. LifeMD's figure is provider-stated (captured 2026-08-05) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's semaglutide ladder runs $453 a month billed monthly. LifeMD's runs $348 a month billed monthly. On the twelve-month basis LifeMD's $4,176 beats Hims & Hers's $5,436 by $1,260 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, LifeMD is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. LifeMD works with insurance pathways while Hims & Hers is cash-pay only — decisive if you hold coverage worth using (the indication doors map when you do), irrelevant if you're paying cash either way.
Structure, side by side
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
LifeMD
- Membership$149/mo
- Dose policyFlat at published rate
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
What our desk is watching on each
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
LifeMD: Highest all-in compounded tirzepatide in the index; the value case rests on clinical service and insurance help, not price.
Questions people ask
Is Hims & Hers or LifeMD cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Hims & Hers vs LifeMD miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Hims & Hers and LifeMD cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $6,576 at Hims & Hers and $7,164 at LifeMD — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Hims & Hers · LifeMD. Official sites: Hims & Hers ↗ · LifeMD ↗. Nothing here is medical advice.